- 2021-IgAcademyProgram
- Beyond Infection | Part 3 - The Complex Primary Immunodeficient Patient
- Beyond Infection | The Realities of Primary Immunodeficiency - A CE Supplement
- Beyond Infection: The Realities of Primary Immunodeficiency | Webinar Series
- Beyond Infection: The Realities of Primary Immunodeficiency. A CE | CME Supplement. (copy)
- Beyond Infection: The Realities of Primary Immunodeficiency. A CE Supplement.
- Bronchiectasis in Primary Immunodeficiency
- Building a Culture of Safety: No Heroes Allowed
- Building a Culture of Safety: No Heroes Allowed | 2023
- Childhood Post-Infectious Autoimmune Encephalopathy
- Clinical Update in the Diagnosis, Treatment, and Management of CIDP
- Clinical Updates in the Management of CIDP
- Compliance and Risk Management
- Controversies in CIDP: Targeting Remission vs. Stabilization
- Coordinating Immunomodulator & IVIG: The Good, The Bad, The Ugly
- CVID: Overview of Genetic Causes and Diagnostic Testing
- Diagnosing and Treating PANS and PANDAS in a Multispecialty Center
- Enhancing Patient Quality of Life: Roles and Responsibilities in a Healthcare Professional Team
- Exercising with Peripheral Neuropathy
- Exploring Novel Approaches to Treatment of Myasthenia Gravis
- Exploring Novel Approaches to Treatment of Myasthenia Gravis | 2023
- How to Support Patients Who are Isolated or Lonely
- Ig Academy for Clincians
- Ig Academy Virtual Review Course
- Ig Certified Nurse Prep Course
- Ig Certified Nurse Review Course
- Ig Manufacturing Process: Past, Present, and Future
- Ig Product Selection Strategies
- Ig Related Aseptic Meningitis
- Ig Therapy for Antibody Mediated Diseases
- Ig Therapy for Antibody Mediated Diseases | 2023
- Ig Therapy Foundational Review
- Ig Therapy Foundational Review - 2023
- Ig Through the Ages
- Ig Treatment Planning
- Ig Treatment Planning | 2023
- IgCN Review Course-2022
- IgCP Review Course-2022
- IgNS Patient 360 On Demand Conference
- Ins and Outs of Ig Reimbursements
- IV Access in Special Populations and Chronic Illness
- IVIG for Skin Autoimmunity
- IVIg in the Treatment of Autoimmune Blistering Diseases
- IVIg in the Treatment of Autoimmune Blistering Diseases | 2023
- Legislative and Reimbursement Updates
- Multi-therapy Approaches to Management of Myasthenia Gravis
- Multi-therapy Approaches to Management of Myasthenia Gravis | 2023
- Needle Phobia, Pain, Anxiety, and Therapy Avoidance
- Needle Phobia, Pain, Anxiety, and Therapy Avoidance | 2023
- Nutrition in Autoimmune Disease
- Part 1. Primary Immunodeficiency: An Overview
- Part 1. Primary Immunodeficiency: An Overview | 2023 Copy
- Part 1. Primary Immunodeficiency: An Overview | 2024 JA
- Part 2. Autoinflammatory Disorders
- Part 2. Autoinflammatory Disorders | 2023
- Part 3. The Complex Primary Immunodeficient Patient
- Part 3. The Complex Primary Immunodeficient Patient | 2023
- Part 4. Pulmonary Complications of Primary Immunodeficiency
- Part 4. Pulmonary Complications of Primary Immunodeficiency | 2023
- Part 5. Immune Dysregulation
- Part 5. Immune Dysregulation | 2023
- Part 6. Secondary Immune Deficiencies from Biological Agents
- Part 6. Secondary Immune Deficiencies from Biological Agents | 2023
- Patient 360
- Pharmacogenomics: Evidence and Thinking
- Plasma donation and Call to Action
- Plasma Protein Therapeutics Association: Keeping Plasma and Patients Safe
- Plasma Protein Therapeutics Association: Keeping Plasma and Patients Safe | 2023
- Plasma Therapies Analyzed: Growth, Supply, and the Future
- Post-Traumatic Stress Disorder in Healthcare Workers
- Post-Traumatic Stress Disorders in Healthcare Professionals during COVID-19
- Practical Applications in the Care of the Neurology Patient
- Primary Immune Deficiency in Geriatric Patients
- Primary Immune Deficiency in Geriatric Patients | 2023
- Psychosocial Issues in Chronic Illness
- Rheumatologic Disorders and Ig Therapy
- Solid Organ Transplantation
- The Immunology of COVID-19
- The Intersection of Immune Deficiency and Autoimmunity
- The Intersection of Immune Deficiency and Autoimmunity | 2023
- The Role of Subcutaneous Immunoglobulin in Myasthenias Gravis and CIDP
- The Scarlet Letter: Anti-A and Anti-IgA
- Therapeutic Advances in MG
- Through the Rough Waters of Supply Interruptions
- Transcultural Competence | Much More Than You Might Think
- Transcultural Competence: Much More Than You Might Think
- Understanding Stiff Person Syndrome
- Updates on the Management and Treatment of CIDP
- Updates on the Management and Treatment of CIDP | 2023
- Updates on the Management of CIDP - CE White Paper
- What's up on the Hill? 2020 Edition
- When the Sky is Falling: Policies, Protocols and Standards